1. History of erythropoiesis-stimulating agents, the development of biosimilars, and the future of anemia treatment in nephrology;Kalantar-Zadeh;Am J Nephrol,2017
2. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Bikbov;Lancet,2020
3. Prevalence of anemia in chronic kidney disease in the United States;Stauffer;PLoS One,2014
4. Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States;St Peter;BMC Nephrol,2018
5. Prevalence and risk factors of CKD anemia in the United States;Davis;J Am Soc Nephrol,2019